AG
ACOR

Aperio Group’s Acorda Therapeutics ACOR Stock Holding History

Aperio Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$25K Buy
+298
New +$27.4K ﹤0.01% 2423
2020
Q3 		– Sell
-122
Closed -$11K – 2400
2020
Q2 		$11K Buy
+122
New +$12.9K ﹤0.01% 2329
2019
Q4 		– Sell
-86
Closed -$29K – 2351
2019
Q3 		$29K Sell
86
-32
-27% -$17.4K ﹤0.01% 2295
2019
Q2 		$108K Buy
118
+33
+39% +$40.6K ﹤0.01% 2368
2019
Q1 		$135K Sell
85
-8
-9% -$14.4K ﹤0.01% 2215
2018
Q4 		$173K Sell
93
-13
-12% -$28.3K ﹤0.01% 2165
2018
Q3 		$251K Sell
106
-12
-10% -$37.1K ﹤0.01% 2098
2018
Q2 		$406K Sell
118
-13
-10% -$39.8K ﹤0.01% 1847
2018
Q1 		$372K Buy
131
+20
+18% +$59.9K ﹤0.01% 1840
2017
Q4 		$285K Sell
111
-4
-3% -$11.4K ﹤0.01% 1967
2017
Q3 		$325K Buy
115
+7
+6% +$18.4K ﹤0.01% 1878
2017
Q2 		$256K Buy
108
+3
+3% +$5.94K ﹤0.01% 1979
2017
Q1 		$265K Buy
+105
New +$302K ﹤0.01% 1885
2016
Q4 		– Sell
-105
Closed -$262K – 2142
2016
Q3 		$262K Buy
+105
New +$313K ﹤0.01% 1791
2016
Q2 		– Sell
-77
Closed -$246K – 2045
2016
Q1 		$246K Sell
77
-19
-20% -$78.9K ﹤0.01% 1766
2015
Q4 		$495K Buy
96
+26
+37% +$114K ﹤0.01% 1343
2015
Q3 		$221K Buy
70
+7
+11% +$27.1K ﹤0.01% 1715
2015
Q2 		$252K Buy
+63
New +$243K ﹤0.01% 1733
2015
Q1 		– Sell
-53
Closed -$261K – 2006
2014
Q4 		$261K Buy
+53
New +$227K ﹤0.01% 1597

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Aperio Group's ACOR Position: Q4 2020 in Review

Aperio Group opened a new position in Acorda Therapeutics (ACOR) in Q4 2020: 298 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #2423 among its holdings. This is a return to the name: Aperio Group previously reported a position in ACOR as recently as Q2 2020.

Aperio Group first reported a position in ACOR in Q4 2014 and has held it in 19 quarters since. The position peaked at $495K in Q4 2015. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.

  • Aperio Group held 298 shares of Acorda Therapeutics worth $25K as of Q4 2020.
  • Acorda Therapeutics was a new Aperio Group position in Q4 2020.
  • Acorda Therapeutics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2423 holding.
  • Aperio Group first reported a position in Acorda Therapeutics in Q4 2014 and has held it in 19 quarters since.
  • Aperio Group's Acorda Therapeutics position peaked at $495K in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.